Skip to main content
Aptamer Sciences Inc logo

Aptamer Sciences Inc — Investor Relations & Filings

Ticker · 291650 ISIN · KR7291650000 KO Manufacturing
Open in API
Filings indexed 230 across all filing types
Latest filing 2024-01-17 Report Publication Anno…
Country KR South Korea
Listing KO 291650

About Aptamer Sciences Inc

https://aptsci.com/en/

Aptamer Sciences Inc. is a clinical-stage biopharmaceutical company specializing in aptamer technology. The company has established a proprietary, integrated platform for the discovery and development of aptamer-based therapeutics and diagnostics. Its primary focus is on oncology, utilizing its Aptamer-Drug Conjugate (ApDC™) platform to create targeted cancer treatments. The lead candidate, AST-201, is an ApDC targeting the GPC3 protein, which is highly expressed in solid tumors such as liver cancer. The company is advancing AST-201 through clinical trials to evaluate its safety and efficacy. The development pipeline also includes other innovative platforms like Aptamer Radioligand Conjugates (ApRC) and Aptamer Immune Stimulator Conjugates (ApIS), aimed at addressing unmet medical needs in hemato-oncology and other areas. Aptamer Sciences leverages its technology to develop novel therapies with the potential for high specificity and efficacy.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It does not contain the actual presentation slides or financial data, but rather serves as a notification of the event and where the materials will be posted. Under the 'Menu vs Meal' rule, this is an announcement of an event/report, fitting the 'Report Publication Announcement' or general regulatory filing category. Given the specific nature of IR event scheduling, 'RPA' is the most appropriate classification.
2024-01-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by major shareholders and special related parties (specifically, the resignation of an executive, Kim Yun-dong, leading to a change in the reported shareholding). This type of filing is a regulatory requirement for significant shareholding changes, which falls under the 'Major Shareholding Notification' category.
2024-01-05 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 1% confidence The document is a short regulatory notice regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or voting results, but rather serves as a formal regulatory announcement of the procedural steps for the meeting. Given it is a standard regulatory notification that does not fit into specific categories like 'DVA' (results) or 'AGM-R' (presentation materials), it falls under the general regulatory filing category.
2023-12-15 Korean
분기보고서 (2023.09)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Aptamer Sciences' (주식회사 압타머사이언스) covering the period from 2023.01.01 to 2023.09.30. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-11-14 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status of major shareholders, including changes in ownership percentages and the purpose of holding. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes.
2023-09-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as an 'Insider Trading Report' or 'Director's Dealing' report) where company executives or major shareholders disclose changes in their shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2023-09-27 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.